Видео ютуба по тегу Atossa Therapeutics

Доктор Стивен Куэй, доктор медицинских наук, генеральный директор компании Atossa Therapeutics — ...
Доктор Стивен Куэй, доктор медицинских наук, генеральный директор компании Atossa Therapeutics — ...
Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook
Inside Atossa Therapeutics: CEO Dr. Steven Quay Talks Pipeline, Progress, and Investor Outlook
Dr. Steven Quay on Market Movers: Advancing Breast Cancer Treatment with V-Endoxifen
Dr. Steven Quay on Market Movers: Advancing Breast Cancer Treatment with V-Endoxifen
ATOS Stock Just Crashed — What Happened to Atossa Therapeutics?
ATOS Stock Just Crashed — What Happened to Atossa Therapeutics?
Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment
Inside Atossa Therapeutics (Nasdaq: ATOS): CEO Dr. Steven Quay on Advancing Breast Cancer Treatment
Atossa Therapeutics: This Drug Developer Is Dedicated To “Transforming The Breast Cancer Paradigm”
Atossa Therapeutics: This Drug Developer Is Dedicated To “Transforming The Breast Cancer Paradigm”
Atossa Therapeutics Company Overview: Disrupting the Breast Cancer Paradigm
Atossa Therapeutics Company Overview: Disrupting the Breast Cancer Paradigm
A Reminder To Get Your Mammograms from Atossa Therapeutics
A Reminder To Get Your Mammograms from Atossa Therapeutics
Atossa Therapeutics: My Take on Their Reverse Stock Split Strategy
Atossa Therapeutics: My Take on Their Reverse Stock Split Strategy
Atossa Therapeutics (Nasdaq: ATOS) Investor Webinar - August 6th, 2025
Atossa Therapeutics (Nasdaq: ATOS) Investor Webinar - August 6th, 2025
Atossa Therapeutics: Advancing a New Era in Breast Cancer Treatment
Atossa Therapeutics: Advancing a New Era in Breast Cancer Treatment
Atossa Therapeutics: My Take on Their Reverse Stock Split Strategy
Atossa Therapeutics: My Take on Their Reverse Stock Split Strategy
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Results: Endoxifen Reduces Breast Density
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Results: Endoxifen Reduces Breast Density
Почему акции ATOS перепроданы, есть ли возможность для снижения? Краткий ответ: ДА
Почему акции ATOS перепроданы, есть ли возможность для снижения? Краткий ответ: ДА
Atossa Therapeutics Press Release Dated March 11, 2021
Atossa Therapeutics Press Release Dated March 11, 2021
Atossa Therapeutics calls for at-risk women to begin breast cancer screening at 35
Atossa Therapeutics calls for at-risk women to begin breast cancer screening at 35
Atossa Therapeutics: Мой главный вывод из формы 8-K
Atossa Therapeutics: Мой главный вывод из формы 8-K
"Atossa Therapeutics (NASDAQ: ATOS) Redefining Breast Cancer Prevention and Treatment” 5-4-2023